Profile of:

Praveena Chiowchanwisawakit

Full name: Praveena Chiowchanwisawakit

Current country: Thailand

Membership level: Full

Type of membership: Member

Number of publications: 13

Cost-Utility Analysis of Biologic Disease-Modifying Antirheumatic Drugs for Patients With Psoriatic Arthritis in Thailand (2023)

Using the patient-acceptable symptom state to evaluate patients’ perspectives of living with psoriasis: A cross-sectional study (2022)

Tumor Necrosis Factor Inhibitors Reduce Spinal Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: A Longitudinal Analysis From the Alberta Prospective Cohort. (2021)

The ASAS-OMERACT core domain set for axial spondyloarthritis. (2021)

Younger age of onset and uveitis associated with HLA-B27 and delayed diagnosis in Thai patients with axial spondyloarthritis (2021)

HLA-B*27:04 associated with enthesitis and younger age of onset, and HLA-B allele profile in patients with ankylosing spondylitis in Thailand: A cross-sectional study. (2021)

Association between syndesmophyte and metabolic syndrome in patients with psoriatic arthritis or ankylosing spondylitis: a cross-sectional study (2021)

Disease activity is associated with spinal radiographic progression in axial spondyloarthritis independently of exposure to tumour necrosis factor inhibitors. (2021)

Effectiveness and Drug Survival of Anti-Tumor Necrosis Factor alpha Therapies in Patients With Spondyloarthritis: Analysis From the Thai Rheumatic Disease Prior Authorization Registry (2019)

2018 APLAR axial spondyloarthritis treatment recommendations. (2019)

Disease activity and functional status associated with health-related quality of life and patient-acceptable symptom state in patients with psoriatic arthritis in Thailand: A cross-sectional study. (2019)

Relationship Between Health-Related Quality of Life and Patient Acceptable Symptom State With Disease Activity and Functional Status in Patients With Ankylosing Spondylitis in Thailand (2019)

Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis. (2018)